Well I have tried to communicate with company with no reply. It's a fairly obvious question isn't it? Why is the same treatment that didn't get put forward for a CE mark in 2009 going to get put forward in 2015 with no new information? Do they think they'll get it on the back of Sirtex? Personally I can't think of many oncology services that are going to be recommending a treatment to patients that has no controlled data on efficacy. There has to be some form of capital raising coming up in the near future to pay for a controlled trial - no you can't do it for nearly free expecting patients to pay for it (!).
Well I have tried to communicate with company with no reply....
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.010(0.93%) |
Mkt cap ! $20.14M | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.08 | $1.06 | $16.77K | 15.64K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 6725 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 11531 | 2 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |